Skip to main content

Table 2 Treatment administered to patients with recurrent pancreatic ductal adenocarcinoma

From: Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study

Characteristics

Number = 140 (%)

Chemotherapy for rPDAC

 Single Agent

19 (13)

 Non-Standard Combination

47 (34)

 Standard Combination

74 (53)

Lines of chemotherapy for rPDAC

 1

73 (52)

 2

47 (34)

 3

15 (11)

 4–6

5 (3)

  1. rPDAC: recurrent pancreatic ductal adenocarcinoma
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us